Alivus Life Sciences Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 74.85% of Alivus Life Sciences, FIIs hold 5.93%, DIIs hold 7.03% and the public holds 12.19%. Promoter holding fell by 0.02 percentage points from Jun 2026.
Get an alert when Alivus Life Sciences reports results or its shareholding changes. Free account.
Promoters
74.85%
−0.02 pp QoQ
FIIs
5.93%
+0.39 pp QoQ
DIIs
7.03%
−0.15 pp QoQ
Public
12.19%
−0.23 pp QoQ
Alivus Life Sciences shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 74.85% | 5.93% | 7.03% | 12.19% | 1,22,777 |
| Jun 2026 | 74.87% | 5.54% | 7.18% | 12.42% | 1,25,559 |
| Mar 2026 | 74.87% | 5.30% | 7.27% | 12.55% | 1,27,969 |
| Dec 2025 | 74.91% | 5.08% | 7.13% | 12.89% | 1,32,748 |
| Sep 2025 | 74.91% | 6.84% | 5.47% | 12.79% | 1,35,643 |
| Jun 2025 | 74.94% | 6.42% | 5.62% | 13.03% | 1,38,500 |
| Mar 2025 | 74.99% | 6.57% | 5.19% | 13.25% | 1,41,977 |
| Dec 2024 | 75.00% | 6.74% | 4.86% | 13.40% | 1,46,840 |
| Sep 2024 | 75.00% | 7.85% | 4.16% | 12.99% | 1,43,960 |
| Jun 2024 | 82.85% | 4.81% | 1.57% | 10.76% | 1,49,396 |
| Mar 2024 | 82.85% | 5.01% | 1.41% | 10.73% | 1,56,183 |
| Dec 2023 | 82.85% | 4.57% | 0.74% | 11.84% | 1,85,531 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹17.93k cr, the promoter group's 74.85% stake is worth ₹13.42k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Alivus Life Sciences shareholding: common questions
What is the promoter holding in Alivus Life Sciences?
Promoters hold 74.85% of Alivus Life Sciences as of Sep 2026. Their stake fell by 0.02 percentage points from Jun 2026.
How much do FIIs hold in Alivus Life Sciences?
Foreign institutional investors (FIIs) held 5.93% of Alivus Life Sciences in Sep 2026, +0.39 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Alivus Life Sciences?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 7.03% of Alivus Life Sciences in Sep 2026, −0.15 pp versus Jun 2026.
Is the promoter holding in Alivus Life Sciences pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Alivus Life Sciences.
How has Alivus Life Sciences's promoter holding changed in the last year?
Promoter holding moved from 74.91% in Sep 2025 to 74.85% in Sep 2026 (−0.06 pp).
How many shareholders does Alivus Life Sciences have?
Alivus Life Sciences had 1,22,777 shareholders in Sep 2026, compared with 1,25,559 in Jun 2026.